News & Analysis on Clinical Trial Services & Contract Research And Development
Dispatches from PCT US
As M&A continues to ramp up for the pharma and biotech industry, communication and agility are two of the major keys for CROs to adapt to an acquisition, experts said Thursday at the Partnerships in Clinical Trials Conference in Boston.
Thermo Fisher has added X-MAN cell line services to its biopharma R&D offerings through a supply agreement with Horizon Discovery Group.
Cheaper disposable manufacturing techs and increased demand for outsourced production will see more CMOs enter the contracting sector according to HighTech Business Decisions